-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - New Episodes of DMARD Use
We identified 10,547 episodes of new use of DMARD
therapies in 6018 patients … The median
number of episodes per patient was 1 (range, 1–12). … Biologic DMARDs accounted for 10% of episodes. … Persistence on DMARD Therapies During New Episodes of Use
No. … Adherence to DMARD Therapies During New Episodes of Use
Adherence Within Episodes
No. of New
Episodes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0663-131114.pdf
April 10, 2013 - combinations of these, and placebo/sham
Outcome(s): Improvement in symptoms of manic, mixed, or depressive episodes … ;
prevention of recurrent bipolar episodes; reduced suicide risk; improved treatment
adherence, improved … medications, and other somatic treatments (e.g., electroconvulsive therapy)
in specific types of bipolar episodes … )
Bipolar disorder is characterized by recurrent episodes of mania and depression, which generally
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - Placebo:
o The median difference of incontinence episodes per day, n(%) was significantly
lower in … Placebo
o The median difference of incontinence episodes per day, n(%) was significantly
lower in … Placebo
Median difference of
Incontinence episodes per day,
n(%):
-0.3 (-7.7); p≤0.001
NA None … difference of Urgency episodes per day, n (%):
-1.0 (-13.1); p≤0.001
G. … Placebo
Mean change from baseline at 12 week in daily UI episodes
(Mean± SD): -3.0 ±2.8 vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
Acute Treatments for Episodic Migraine:
Surveillance Report 2
Literature Update Period: September 2, 2021, Through December 30, 2021
Background and Purpose
This report is the second surveillance report for the Agency for Healthcare Research and
Quali…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third and final surveillance report for the Agency for Healthcare Research
an…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-fecal-incontinence-supporting.pdf
June 19, 2020 - Additionally, the number
of incontinence episodes during 2-week time periods decreased from a median … , with individuals
considered to be responders if they
experienced a ≥50% reduction in FI
episodes … RESULTS: Before treatment, the mean number of incontinence
episodes over 2 weeks was 20.7 (median 16 … The median number of FI episodes declined by 68.8% (P <
0.001). … Episodes of both solid and liquid stool incontinence decreased.
-
effectivehealthcare.ahrq.gov/products/bipolar-disorder-treatment/research-protocol
June 23, 2014 - Usually, the person also has depressive episodes, typically lasting at least two weeks. … episodes, but no full-blown manic or mixed episodes. … family
Remission/Prevention of episodes
Increased time between episodes/Time to remission
Reduced …
Mixed Episodes
X
Table 6. …
Mixed Episodes
Table 7.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
1
Acute Treatments for Episodic Migraine:
Surveillance Report 2
Literature Update Period: September 2, 2021, Through December 30, 2021
Background and Purpose
This report is the second surveillance report for the Agency for Healthcare Research and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
Qual…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3
1
Acute Treatments for Episodic Migraine:
Surveillance Report 3
Literature Update Period: December 31, 2021, through March 21, 2022
Background and Purpose
This report is the third surveillance report for the Agency for Healthcare Research and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bipolar-disorder-treatment_research-protocol.pdf
June 23, 2014 - Usually, the person also has
depressive episodes, typically lasting at least two weeks. … episodes, but no full-blown
manic or mixed episodes. … family
• Remission/Prevention of episodes
• Increased time between episodes/Time to
remission
• … Mixed Episodes --
Note: shaded cells not valid group. … Mixed Episodes
Table 7.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
May 01, 2017 - Children
with chronic OME are prone to recurrent
AOM episodes, and after an AOM episode
all children … and less troublesome than AOM episodes in children with
intact eardrums.10 However, otorrhea may be … Casselbrant 1992 reported the rate of new episodes per
arm was 1.08 in the placebo group versus 1.02 … of AOM/otorrhea only in those subjects whose
episodes of AOM occurred year round. … and the overall number of episodes of recurrent
AOM.
-
effectivehealthcare.ahrq.gov/products/depression-care-distributed-networks/abstract
May 08, 2009 - Improve the ability to define episodes of illness to evaluate therapeutic outcomes. … phases:
Phase 1: Claims Database Study
Utilization - Conduct population-based cohort studies of new episodes … POC data will be used in two ways: (1) as a method to establish the start and end dates of depression episodes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - the definition of BED remission and recovery, the
term “abstinence” is used to mean 0 binge-eating episodes … to reflect a more sustained, global state of change marked by the
absence not only of binge-eating episodes … 1.67; 95% CI 1.24 to 2.26). ���
7 (MAc) 331 Antidepressants decreased the frequency of binge-eating episodes … Applicable to DSM-5 only, BED severity is graded as follows:
�� Mild: 1 to 3 episodes per week
�� Moderate … : 4 to 7 episodes per week
�� Severe: 8 to 13 episodes per week
�� Extreme: 14 or more episodes per week
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_clinician.pdf
July 01, 2016 - Fecal incontinence is the recurrent involuntary loss of
feces, which is defined by the frequency of episodes … Treatment goals are to decrease the frequency and
severity of fecal incontinence episodes. … supplementation with
psyllium vs. placebo
1 206 Severity Psyllium significantly decreased FI by 2.5 episodes … significant difference in the percentage of patients with a 50-percent
or greater reduction in FI episodes … However, the median decrease in the number of FI episodes over 2 weeks was
not significantly different
-
effectivehealthcare.ahrq.gov/products/nsaids-gastroprotective-therapy/research
December 02, 2009 - To decrease potential "channeling" bias, the study included only new episodes of prescribed NSAID or … There were 234,010 and 48,710 new episodes of NSAID and coxib use, respectively, with 363,037 person-years
-
effectivehealthcare.ahrq.gov/products/migraine-treatments
January 08, 2020 - Treatments for Acute Episodic Migraine
Timeline
January 06, 2020
Topic Initiated
January 08, 2020
Research Protocol
Treatments for Acute Episodic Migraine
December 29, 2020
Systematic Review
Acute Treatments for Episodic M…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0768-141211.pdf
October 23, 2014 - PICO
Population(s): Children, ages 1 to 18, who experience recurrent throat infections (at
least 7 episodes … in the past year, at least 5 episodes per year for 2 years, or at least 3
episodes per year for 3 years
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine
Comparative Effectiveness Review
Number 239
Acute Treatments for Episodic Migraine
Evidence Summary
Main Points
• Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti-
inflammatory drugs), dihydroergotamine, antieme…